HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1518663Generated: October 27, 2026
Sodium hydride → chloromethyl 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinoline-1(2H)-carboxylate
https://huagongshe.com/reaction/1518663
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | Aripiprazole | HCID 60795 | — |
| Reactant | Chloromethyl chloroformate | HCID 62754 | — |
| Solvent | 2-Methyltetrahydrofuran | HCID 7301 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | chloromethyl 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinoline-1(2H)-carboxylate | HCID 66810238 | — |
Reaction Steps
To a suspension of aripiprazole (2 g, 4.46 mmol) in 2-methyltetrahydrofuran (40 mL) was added NaH (357 mg, 8.92 mmol). After 20 minutes, further 2-methyltetrahydrofuran (20 mL) was added to aid stirring. Chloromethyl chloroformate (1.19 mL, 13.38 mmol) was then added and the reaction stirred for 2 days. The reactions were combined for work up. The reaction was cooled to 0° C., diluted with ethyl acetate (50 mL) and quenched with aqueous saturated NaHCO3 solution (50 mL). The reaction was extracted with ethyl acetate (3×50 mL) and the combined organics washed with brine (100 mL), then dried (MgSO4) and concentrated to give chloromethyl 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinoline-1(2H)-carboxylate (crude yield 2.59 g) as 3:2 mixture of product/aripiprazole. The product was not purified due to instability during silica chromatography and so taken onto the next step crude.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09072788B2 |
|---|
| Source dataset | uspto-grants-2015_07 |
|---|
| ORD ID | ord-74036e2b1a8a4d01aaf97e84ba7d09b4 |
|---|
| Source note | uspto-grants-2015_07 |
|---|